Evidence map›Paper›PMID 35900089›Full record

ArticleMicrobiology spectrum2022

Taís C Silva, Ana C Mengarda, Bruna L Lemes, Susana A Z Lescano, Dalete Christine S Souza, João Henrique G Lago, Josué de Moraes

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Phenotypic Screening of HPharmaceuticals (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Antihistamines HACS omega · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Taís C SilvaNúcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, São Paulo, Brazil.
Ana C MengardaNúcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, São Paulo, Brazil.
Bruna L LemesNúcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, São Paulo, Brazil.
Susana A Z LescanoInstituto de Medicina Tropical, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil.
Dalete Christine S SouzaCentro de Ciências Naturais e Humanas, Universidade Federal do ABCgrid.412368.a, Santo André, São Paulo, Brazil.
João Henrique G LagoCentro de Ciências Naturais e Humanas, Universidade Federal do ABCgrid.412368.a, Santo André, São Paulo, Brazil.
Josué de MoraesNúcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, São Paulo, Brazil.ORCID 0000-0003-1766-7031
Guarulhos University · BRUniversidade Federal do ABC · BRUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections caused by parasitic helminths have enormous health, social, and economic impacts worldwide. The treatment and control of these diseases have been dependent on a limited set of drugs, many of which have become less effective, necessitating the search for novel anthelmintic agents. In this study, a simplified compound,

Indexed as

AnthelminticsToxocara canisToxocariasisAlbendazoleAnimalsHumansAlbendazoleAnthelminticsalbendazoleantiparasitic agentshelminthiasismolecular simplificationneglected diseasesToxocara canistoxocariasis

Identifiers

PMID35900089
PMCPMC9431031
OpenAlexW4288096649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.